Guillain-Barré Syndrome following Treatment with Sunitinib Malate

Sunitinib malate (Sutent, SU011248) is an oral multitargeted tyrosine kinase inhibitor (TKI) used for the treatment of metastatic renal cell carcinoma and imatinib (Gleevec)—resistant gastrointestinal stromal tumor (GIST) with few reported side effects including asthenia, myelosuppression, diarrhea,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanaan, Ziad, Kulairi, Zain, Titianu, Mirela, Saha, Sandip, Kumar, Sarwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074976/
https://www.ncbi.nlm.nih.gov/pubmed/25018885
http://dx.doi.org/10.1155/2014/712040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074976/
https://www.ncbi.nlm.nih.gov/pubmed/25018885
http://dx.doi.org/10.1155/2014/712040

Ejemplares similares